Metraipolis › archive › dc_a661d83ab418
Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Subgroup Analyses of Post-Marketing Surveillance Data by… — Europe PMC PMID:41164972
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41164972
- DOI
- 10.1002/cam4.71177
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T20:52:36.742Z
- SHA-256 of the archived text
60f16fd8c4a12f738f4b735ba59e647ac4a47d1e41de3e2b423780fce567373e- Stable URL of this page
https://metraipolis.com/documento/dc_a661d83ab418
How to cite
Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Subgroup Analyses of Post-Marketing Surveillance Data by… — Europe PMC PMID:41164972 — Europe PMC (en), https://europepmc.org/article/MED/41164972 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a661d83ab418 (Metraipolis archive dc_a661d83ab418, sha256 60f16fd8c4a12f738f4b735ba59e647ac4a47d1e41de3e2b423780fce567373e)
BibTeX
@misc{dca661d83ab418,
title = {Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Subgroup Analyses of Post-Marketing Surveillance Data by… — Europe PMC PMID:41164972},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41164972},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a661d83ab418; sha256 60f16fd8c4a12f738f4b735ba59e647ac4a47d1e41de3e2b423780fce567373e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41164972. Agents can read the archived copy with the MCP tool read_document.